----

DECISION OF THE EUROPEAN PARLIAMENT

of 21 April 2004

concerning discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002

(2004/710/EC)

THE EUROPEAN PARLIAMENT,

having regard to the Court of Auditors' report on the financial statements of the European Agency for the Evaluation of Medicinal Products for the financial year 2002, together with the Agency's replies (1) (C5-0638/2003),

having regard to the Council's recommendation of 9 March 2004 (C5-0143/2004),

having regard to the EC Treaty, and in particular Article 276 thereof,

having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities (2), and in particular Article 185 thereof, and to Council Regulation (EC) No 1647/2003 of 18 June 2003 amending Regulation (EEC) No 2309/93 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products (3), and in particular Article 57a thereof,

having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 on the Financial Regulation applicable to the general budget of the European Communities (4), and in particular Article 94 thereof,

having regard to Rule 93a of and Annex V to its Rules of Procedure,

having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Consumer Policy (A5-0212/2004),

The Secretary-General

Julian PRIESTLEY

The President

Pat COX

----

(1)OJ C 319, 30.12.2003, p. 22.

(2)OJ L 248, 16.9.2002, p. 1.

(3)OJ L 245, 29.9.2003, p. 19.

(4)OJ L 357, 31.12.2002, p. 72.

----

RESOLUTION

of the European Parliament containing the comments accompanying the decision on the discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002

THE EUROPEAN PARLIAMENT,

having regard to the Court of Auditors' report on the financial statements of the European Agency for the Evaluation of Medicinal Products for the financial year 2002, together with the Agency's replies (1) (C5-0638/2003),

having regard to the Council's recommendation of 9 March 2004 (C5-0143/2004),

having regard to the EC Treaty, and in particular Article 276 thereof,

having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities (2), and in particular Article 185 thereof, and to Council Regulation (EC) No 1647/2003 of 18 June 2003 amending Regulation (EEC) No 2309/93 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products (3), and in particular Article 57a thereof,

having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 on the Financial Regulation applicable to the general budget of the European Communities (4), and in particular Article 94 thereof,

having regard to Rule 93a of and Annex V to its Rules of Procedure,

having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Consumer Policy (A5-0212/2004),

Implementation of the budget — Financial rules

Financial statements

Legality and regularity of the underlying transactions

Other

Horizontal points on the Agencies and the Commission

Implementing the new Financial Regulation — Internal audit and control

Financial Management

Review of the agencies

New sources of financing

Harmonised operating framework

Staff policy

----

(1)OJ C 319, 30.12.2003, p. 22.

(2)OJ L 248, 16.9.2002, p. 1.

(3)OJ L 245, 29.9.2003, p. 19.

(4)OJ L 357, 31.12.2002, p. 72.

(5)  This amount includes 5,2 million euro of revenue due in respect of the financial year 2002 (10,7 million euro in 2001).

(6)  Calculation based on the principles of Article 15 of Council Regulation (EC, Euratom) No 1150/2000 of 22 May 2000 (OJ L 130, 31.5.2000, p. 8).

(7)OJ L 148, 16.6.2003, p. 83 and OJ L 333, 20.12.2003, p. 53 (point 18).

(8)  Texts adopted, 13.1.2004, P5_TA(2004) 0015.

(9)OJ L 136, 31.5.1999, p. 15.

(10)  P5_TA(2004) 0015 (paragraphs 13 and 14).

(11)  P5_TA(2004) 0015 (paragraph 24).

(12)  See paragraph 13 of the Court of Auditors'specific report for 2002 (p. 64).

----